The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Carl Borrebaeck

Carl Borrebaeck

Professor

Carl Borrebaeck

Deciphering systemic lupus erythematosus-associated serum biomarkers reflecting apoptosis and disease activity

Author

  • P. Delfani
  • G. Sturfelt
  • B. Gullstrand
  • A. Carlsson
  • M. Kassandra
  • C. A K Borrebaeck
  • A. A. Bengtsson
  • C. Wingren

Summary, in English

Systemic lupus erythematosus (SLE) is a severe chronic inflammatory autoimmune connective tissue disease. Despite major efforts, SLE remains a poorly understood disease with unpredictable course, unknown etiology and complex pathogenesis. Apoptosis combined with deficiency in clearing apoptotic cells is an important etiopathogenic event in SLE, which could contribute to the increased load of potential autoantigen(s); however, the lack of disease-specific protein signatures deciphering SLE and the underlying biological processes is striking and represents a key limitation. In this retrospective pilot study, we explored the immune system as a specific sensor for disease, in order to advance our understanding of SLE. To this end, we determined multiplexed serum protein expression profiles of crude SLE serum samples, using antibody microarrays. The aim was to identify differential immunoprofiles, or snapshots of the immune response modulated by the disease, reflecting apoptosis, a key process in the etiology of SLE and disease activity. The results showed that multiplexed panels of SLE-associated serum biomarkers could be decoded, in particular reflecting disease activity, but potentially the apoptosis process as well. While the former biomarkers could display a potential future use for prognosis, the latter biomarkers might help shed further light on the apoptosis process taking place in SLE.

Department/s

  • EpiHealth: Epidemiology for Health
  • Department of Immunotechnology
  • Rheumatology
  • Lund SLE Research Group
  • BioCARE: Biomarkers in Cancer Medicine improving Health Care, Education and Innovation

Publishing year

2017-04-01

Language

English

Pages

373-387

Publication/Series

Lupus

Volume

26

Issue

4

Document type

Journal article

Publisher

SAGE Publications

Topic

  • Rheumatology and Autoimmunity

Keywords

  • Antibody microarray
  • apoptosis
  • autoantibodies
  • biomarker
  • disease activity
  • systemic lupus erythematosus

Status

Published

Research group

  • Lund SLE Research Group

ISBN/ISSN/Other

  • ISSN: 0961-2033